Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Human Clinical Trial of a Next Generation, Long-acting Injectable, Combination Antiretroviral Therapy Platform

NCT05850728 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT05850728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05850728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Human Clinical Trial of a Next Generation, Long-acting Injectable, Combination Antiretroviral Therapy Platform
Lead sponsor
University of Washington
Phase
Phase 1
Overall status
Completed
Start date
April 1, 2023
Completion date
June 28, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiretroviral therapy, human immunodeficiency virus, treatment